The Study
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
This study watched what happened to rats when they were given a special peptide, and it saw that some injuries seemed to heal faster. But it didn't compare the rats to others who didn't get the peptide, so we can't say for sure the peptide caused the healing.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
Scientists gave a special peptide called BPC 157 to sick rats with damaged stomachs, intestines, and livers — and their bodies healed faster and stronger.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 59 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — if this works in humans, it could help people recover from gut surgery, liver poisoning, or short bowel syndrome much faster.
- 2Rats with gut injuries healed completely even when treatment was delayed by a month; weight returned and gut lining grew thicker within 4 weeks; liver damage was reduced.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Current pharmaceutical design
Year
2011
Authors
P. Sikiric, S. Seiwerth, R. Ručman, B. Turković, D. S. Rokotov, L. Brčić, M. Sever, Robert Klicek, B. Radić, D. Drmic, Spomenko Ilić, D. Kolenc, H. Vrčić, B. Šebečić
Related Content
Claims (5)
In rats with esophageal inflammation and weakened sphincters, BPC 157 restores normal sphincter pressure and decreases inflammation in the esophagus.
In rats undergoing surgical repair of the abdominal aorta, BPC 157 treatment is linked to reduced blood clot formation and restoration of normal blood vessel function.
In rats with surgical wounds in the gastrointestinal tract, BPC 157 causes complete tissue repair even when given one month after injury.
In rats with short-bowel syndrome, daily BPC 157 treatment given by mouth or injection leads to sustained weight gain above pre-surgery levels within four weeks and increases the size of intestinal structures involved in nutrient absorption.
In rats with chemical-induced liver injury, BPC 157 reduces tissue damage through antioxidant activity.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.